X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39288) 39288
Newsletter (3382) 3382
Newspaper Article (925) 925
Book Chapter (278) 278
Magazine Article (219) 219
Transcript (73) 73
Book / eBook (31) 31
Publication (30) 30
Conference Proceeding (20) 20
Dissertation (16) 16
Web Resource (10) 10
Streaming Video (9) 9
Book Review (7) 7
Reference (4) 4
Paper (2) 2
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29266) 29266
atrial fibrillation (25744) 25744
male (16865) 16865
female (16199) 16199
cardiac & cardiovascular systems (13963) 13963
aged (13476) 13476
middle aged (12195) 12195
atrial fibrillation - drug therapy (12155) 12155
stroke (8221) 8221
risk factors (7802) 7802
treatment outcome (6969) 6969
anticoagulants (6746) 6746
atrial-fibrillation (6714) 6714
warfarin (6626) 6626
anticoagulants - therapeutic use (5764) 5764
cardiac arrhythmia (5751) 5751
atrial fibrillation - complications (5502) 5502
care and treatment (5260) 5260
adult (5014) 5014
drug therapy (4997) 4997
aged, 80 and over (4887) 4887
atrial fibrillation - physiopathology (4695) 4695
research (4547) 4547
prevention (4442) 4442
heart (4357) 4357
electrocardiography (4249) 4249
anti-arrhythmia agents - therapeutic use (4217) 4217
catheter ablation (4193) 4193
cardiology (4134) 4134
risk (4108) 4108
cardiovascular (3990) 3990
stroke - prevention & control (3908) 3908
mortality (3904) 3904
management (3732) 3732
fibrillation (3633) 3633
analysis (3621) 3621
atrial fibrillation - therapy (3615) 3615
ablation (3592) 3592
medical research (3366) 3366
atrial fibrillation - diagnosis (3358) 3358
medicine, general & internal (3339) 3339
therapy (3166) 3166
abridged index medicus (3146) 3146
medicine, experimental (3109) 3109
follow-up studies (3101) 3101
retrospective studies (3101) 3101
anticoagulants - administration & dosage (3086) 3086
atrial fibrillation - surgery (3076) 3076
heart failure (3064) 3064
anticoagulants - adverse effects (3050) 3050
time factors (2922) 2922
administration, oral (2853) 2853
peripheral vascular disease (2839) 2839
medicine & public health (2829) 2829
pharmacology & pharmacy (2740) 2740
prospective studies (2723) 2723
patients (2694) 2694
anticoagulation (2626) 2626
warfarin - therapeutic use (2610) 2610
dabigatran (2567) 2567
stroke - etiology (2550) 2550
atrial fibrillation - epidemiology (2535) 2535
animals (2506) 2506
risk assessment (2316) 2316
arrhythmia (2242) 2242
thromboembolism (2220) 2220
atrial fibrillation - etiology (2198) 2198
recurrence (2180) 2180
health aspects (2107) 2107
prognosis (2103) 2103
cardiac patients (2059) 2059
prevalence (1982) 1982
internal medicine (1969) 1969
hypertension (1964) 1964
surgery (1957) 1957
hemorrhage - chemically induced (1950) 1950
rivaroxaban (1908) 1908
incidence (1896) 1896
stroke prevention (1792) 1792
efficacy (1779) 1779
cardiovascular disease (1733) 1733
aspirin (1723) 1723
hematology (1712) 1712
cardiovascular diseases (1692) 1692
catheter ablation - methods (1680) 1680
safety (1669) 1669
clinical trials (1616) 1616
usage (1556) 1556
electric countershock (1546) 1546
antithrombotic therapy (1508) 1508
sinus rhythm (1497) 1497
risk-factors (1483) 1483
anti-arrhythmia drugs (1480) 1480
physical fitness (1444) 1444
warfarin - adverse effects (1432) 1432
echocardiography (1412) 1412
dosage and administration (1407) 1407
atrial fibrillation - prevention & control (1405) 1405
heart-failure (1381) 1381
anti-arrhythmia agents - adverse effects (1365) 1365
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41199) 41199
German (989) 989
French (426) 426
Russian (411) 411
Spanish (405) 405
Japanese (326) 326
Italian (296) 296
Polish (114) 114
Chinese (95) 95
Portuguese (75) 75
Dutch (45) 45
Hungarian (45) 45
Swedish (45) 45
Danish (38) 38
Turkish (27) 27
Norwegian (26) 26
Czech (23) 23
Finnish (20) 20
Hebrew (19) 19
Romanian (15) 15
Serbian (9) 9
Croatian (8) 8
Lithuanian (6) 6
Bulgarian (5) 5
Slovak (5) 5
Korean (4) 4
Icelandic (2) 2
Ukrainian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Belarusian (1) 1
Bosnian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e531S - e575S
Background: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF... 
DIRECT-CURRENT CARDIOVERSION | STROKE PREVENTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | ORAL ANTICOAGULANT-THERAPY | RISK STRATIFICATION SCHEMES | MAJOR VASCULAR EVENTS | PULMONARY-VEIN ABLATION | ACUTE CORONARY SYNDROME | ECHOCARDIOGRAPHY-GUIDED CARDIOVERSION | ANTIARRHYTHMIC-DRUG THERAPY | CRITICAL CARE MEDICINE | Ticlopidine - therapeutic use | Humans | Electric Countershock | Hemorrhage - prevention & control | Dabigatran | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ticlopidine - adverse effects | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Ticlopidine - analogs & derivatives | Atrial Fibrillation - blood | International Normalized Ratio | Stroke - blood | Atrial Flutter - complications | Atrial Flutter - drug therapy | Hemorrhage - chemically induced | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2019, Volume 321, Issue 13, pp. 1261 - 1274
.... DESIGN, SETTING, AND PARTICIPANTS: The Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation trial is an investigator-initiated, open-label, multicenter, randomized trial involving 126 centers in 10 countries... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | MANAGEMENT | EXPERT CONSENSUS STATEMENT | RECOMMENDATIONS | HEART-FAILURE | SURGICAL ABLATION | WORLDWIDE SURVEY | EUROPEAN-SOCIETY | PARTNERSHIP | RADIOFREQUENCY ABLATION | Recurrence | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Humans | Middle Aged | Risk Factors | Atrial Fibrillation - complications | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Male | Hemorrhage - prevention & control | Anti-Arrhythmia Agents - therapeutic use | Atrial Fibrillation - surgery | Stroke - etiology | Anti-Arrhythmia Agents - adverse effects | Atrial Fibrillation - mortality | Heart Arrest - prevention & control | Hemorrhage - etiology | Intention to Treat Analysis | Heart Arrest - etiology | Female | Registries | Aged | Catheter Ablation - adverse effects | Care and treatment | Dosage and administration | Comparative analysis | Atrial fibrillation | Anti-arrhythmia drugs | Heart | Cardiac arrhythmia | Stroke | Mortality | Medical instruments | Health risks | Clinical trials | Rhythm | Drug development | Risk analysis | Ablation | Patients | Bleeding | Catheters | Crossovers | Risk factors | Chemotherapy | Randomization | Fibrillation | Motivation | Death | Drug therapy | Cardiovascular diseases | Online First | Research | Comments | Original Investigation
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial fibrillation... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics
Journal Article
Circulation, ISSN 0009-7322, 07/2018, Volume 138, Issue 5, pp. 527 - 536
.... After the 2016 North American consensus statement on the management of antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, results of pivotal... 
anticoagulants | atrial fibrillation | platelet aggregation inhibitors | stents | CARDIAC & CARDIOVASCULAR SYSTEMS | SYNDROME AND/OR | EUROPEAN ASSOCIATION | CONSENSUS DOCUMENT | VITAMIN-K ANTAGONIST | DUAL ANTIPLATELET THERAPY | RHYTHM ASSOCIATION EHRA | TRIPLE THERAPY | PERIPHERAL VASCULAR DISEASE | ELUTING STENT IMPLANTATION | CARDIOLOGY WORKING GROUP | FOCUSED UPDATE | Anticoagulants - administration & dosage | Percutaneous Coronary Intervention - mortality | Humans | Coronary Artery Disease - blood | Fibrinolytic Agents - adverse effects | Time Factors | Atrial Fibrillation - mortality | Clinical Decision-Making | Platelet Aggregation Inhibitors - administration & dosage | Coronary Thrombosis - prevention & control | Atrial Fibrillation - diagnosis | Drug Therapy, Combination | Coronary Thrombosis - blood | Platelet Aggregation Inhibitors - adverse effects | Coronary Thrombosis - mortality | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Treatment Outcome | Coronary Artery Disease - mortality | Anticoagulants - adverse effects | Evidence-Based Medicine | Consensus | Atrial Fibrillation - blood | Coronary Artery Disease - therapy | Blood Coagulation - drug effects | Coronary Artery Disease - diagnosis | Coronary Thrombosis - etiology | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Dosage and administration | Thrombolytic drugs | Drug therapy | Atrial fibrillation
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2008, Volume 51, Issue 8, pp. 828 - 835
Objectives: To improve the evaluation of the possible antiarrhythmic effect of statins, we performed a meta-analysis of randomized trials with statins on the end point of incidence or recurrence of atrial fibrillation (AF). Background... 
C-REACTIVE PROTEIN | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | MIRACL | CARDIAC-SURGERY | CLINICAL-TRIALS | PREVENTION | ACUTE CORONARY SYNDROMES | RECURRENCE | ELECTRICAL CARDIOVERSION | ATORVASTATIN | Recurrence | Atrial Fibrillation - epidemiology | Atrial Fibrillation - drug therapy | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Incidence | Randomized Controlled Trials as Topic | Studies | Cardiac arrhythmia | Heart attacks | Drug therapy | Cholesterol
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 12/2006, Volume 48, Issue 11, pp. 2340 - 2347
Journal Article
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2019, Volume 321, Issue 13, pp. 1275 - 1285
Journal Article
Circulation, ISSN 0009-7322, 04/2014, Volume 129, Issue 15, pp. 1577 - 1585
BACKGROUND—The optimal long-term antithrombotic treatment of patients with coexisting atrial fibrillation and stable coronary artery disease is unresolved, and commonly, a single antiplatelet agent is added to oral anticoagulation... 
atrial fibrillation | antithrombotic agents | stroke | myocardial infarction | hemorrhage | CARDIAC & CARDIOVASCULAR SYSTEMS | PREVENTION | RISK | ASPIRIN | CONSENSUS DOCUMENT | CLOPIDOGREL | ACUTE MYOCARDIAL-INFARCTION | TRIPLE THERAPY | PERIPHERAL VASCULAR DISEASE | ASSOCIATION | FOCUSED UPDATE | Myocardial Infarction - mortality | Anticoagulants - administration & dosage | Humans | Middle Aged | Hemorrhage - mortality | Warfarin - adverse effects | Male | Warfarin - administration & dosage | Aspirin - administration & dosage | Incidence | Phenprocoumon - administration & dosage | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Atrial Fibrillation - mortality | Platelet Aggregation Inhibitors - administration & dosage | Phenprocoumon - adverse effects | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Stroke - mortality | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Coronary Artery Disease - drug therapy | Coronary Artery Disease - mortality | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Aged | Cohort Studies | Aggregation | Usage | Blood platelets | Atrial fibrillation | Anticoagulants (Medicine) | Drug therapy | Coronary heart disease | Health aspects
Journal Article